07:00 , May 11, 2015 |  BioCentury  |  Emerging Company Profile

Preventing accumulation

InFlectis BioScience S.A.S. is developing preclinical small molecules for Orphan diseases to slow production of misfolded proteins whose accumulation leads to disease. The goal is to turn up one of the three components of the...
08:00 , Mar 5, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Neurology Guillain-Barré syndrome (GBS); chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) Myelin protein zero (MPZ; P0) Studies in mice suggest that targeting P0...